GUGGENHEIM CAPITAL LLC - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 72 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2014. The put-call ratio across all filers is 1.04 and the average weighting 0.6%.

Quarter-by-quarter ownership
GUGGENHEIM CAPITAL LLC ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q1 2016$765,000
-49.9%
85,768
-25.6%
0.00%
-50.0%
Q4 2015$1,528,000
+9.4%
115,273
-13.1%
0.00%0.0%
Q3 2015$1,397,000
-63.0%
132,621
-4.4%
0.00%
-55.6%
Q2 2015$3,775,000
-5.7%
138,706
+6.1%
0.01%0.0%
Q1 2015$4,002,000
-43.5%
130,760
-30.9%
0.01%
-50.0%
Q4 2014$7,083,000
+138.1%
189,258
+122.3%
0.02%
+157.1%
Q3 2014$2,975,000
-29.0%
85,143
-5.5%
0.01%
-36.4%
Q2 2014$4,193,000
+85.1%
90,077
+22.8%
0.01%
+83.3%
Q1 2014$2,265,00073,3290.01%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q3 2014
NameSharesValueWeighting ↓
Palo Alto Investors LP 3,200,396$30,084,0001.72%
TFS CAPITAL LLC 105,040$987,0000.26%
Tekla Capital Management LLC 500,324$4,703,0000.20%
Piermont Capital Management Inc. 51,080$480,0000.11%
ESSEX INVESTMENT MANAGEMENT CO LLC 55,793$524,0000.09%
Candriam S.C.A. 390,000$3,666,0000.08%
Virtus ETF Advisers LLC 27,446$258,0000.08%
SECOR Capital Advisors, LP 66,484$625,0000.08%
Trexquant Investment LP 29,007$273,0000.04%
PRELUDE CAPITAL MANAGEMENT, LLC 32,196$303,0000.04%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders